Daniël Verhoef

4PUBLICATIONS
9CO-AUTHORS
Haematological tumoursBiologically active moleculesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 27, 2026
Safety Pharmacology, Toxicokinetics and Pharmacodynamics of VMX-C001, an Intravenous Bypassing Agent for Factor Xa Inhibitors, in Animal Models.

|Feb 12, 2025
Modifications of the Prothrombin Active Site S4 Subpocket Confer Resistance to Dabigatran.

Viola J F Strijbis, Ka Lei Cheung, Dejvid Veizaj

|Jul 15, 2022
Differences in wild-type- and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies.

Jonathan H Foley, Erald Shehu, Anne Riddell

|Sep 15, 2017
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors.

Daniël Verhoef, Koen M Visscher, C Ruben Vosmeer

Pageof 1

Frequent Collaborators

2 joint publications

Mettine H A Bos

1 joint publications

Daan P Geerke

1 joint publications

Jonathan H Foley

1 joint publications

John Little